SEC Form 4 · accession 0001209191-18-023388
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Emerald Health Sciences Inc.
10% Owner
Period of report
Mar 29, 2018
Accepted (ET)
Apr 3, 2018 · 9:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 29, 2018 | C | 12,335,000 | $0.10 | A | 53,116,250 | D | |
| Common Stock | Mar 29, 2018 | C | 20,000,000 | $0.10 | A | 73,116,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred StockF1 | $0.10 | Mar 29, 2018 | C | 1,234 | D | — | — | Common Stock | 12,335,000 | 0 | D |
| Series F Convertible Preferred StockF2 | $0.10 | Mar 29, 2018 | C | 2,000 | D | — | — | Common Stock | 20,000,000 | 0 | D |
Explanation of responses
- F1The Series B Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date.
- F2The Series F Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date.